Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05006885
What this trial is testing

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Altimmune, Inc. 95
Not applicableActive Not RecruitingNCT05479721
What this trial is testing

LITMUS Imaging Study

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
University of Oxford 450
Not applicableEnded earlyNCT05292352
What this trial is testing

Prevention of NAFLD in Hispanic Children

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Emory University 103
Not applicableStudy completedNCT06176079
What this trial is testing

Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNon Alcoholic Steatohepatitis+2 more
Michael Ohliger, MD PhD 44
Testing effectiveness (Phase 2)Study completedNCT03938246
What this trial is testing

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Sagimet Biosciences Inc. 142
Not applicableUnknownNCT06080386
What this trial is testing

UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University Hospital, Angers 100
Not applicableUnknownNCT06266559
What this trial is testing

Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Chang Gung Memorial Hospital 60
Testing effectiveness (Phase 2)UnknownNCT05941910
What this trial is testing

The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Attikon Hospital 60
Large-scale testing (Phase 3)Study completedNCT04197479
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 1,343
Not applicableStudy completedNCT02367742
What this trial is testing

Effect of Physical Activity on NAFLD

Who this might be right for
NAFLD
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 100
Not applicableUnknownNCT06325254
What this trial is testing

Clinical Characteristics of Metabolic Associated Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver DiseaseClinical Features
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 3,000
Not applicableNot Yet RecruitingNCT02933554
What this trial is testing

Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis

Who this might be right for
ObesityWeight LossBody Weight+3 more
Keith Pereira, MD: 8
Not applicableLooking for participantsNCT06591169
What this trial is testing

Lifestyle Changes in PCOS with OSA and NAFLD

Who this might be right for
PCOSNAFLDOSA
Cairo University 40
Not applicableLooking for participantsNCT04141592
What this trial is testing

Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Queen Mary University of London 153
Not applicableUnknownNCT04191044
What this trial is testing

Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)

Who this might be right for
Fatty Liver Disease
Instituto de Investigación Marqués de Valdecilla 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05464784
What this trial is testing

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Who this might be right for
Diabetes Mellitus, Type 2HypertriglyceridemiaNon-Alcoholic Fatty Liver Disease
MediciNova 40
Large-scale testing (Phase 3)Study completedNCT02216552
What this trial is testing

Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents

Who this might be right for
NAFLDTYPE 2 DIABETESMETABOLIC SYNDROME
University of Manitoba 10
Not applicableLooking for participantsNCT05309863
What this trial is testing

Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease

Who this might be right for
Pediatric Non-alcoholic Fatty Liver Disease
University Hospital, Ghent 850
Not applicableStudy completedNCT02923804
What this trial is testing

Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients

Who this might be right for
Non Alcoholic Fatty Liver
Pronova BioPharma 172
Post-approval studies (Phase 4)Study completedNCT03068065
What this trial is testing

Antidiabetic Effects on Intrahepatic Fat

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Next Page